Alaunos Therapeutics Inc (TCRT)
1.90
+0.01
(+0.74%)
USD |
NASDAQ |
Dec 27, 09:45
Alaunos Therapeutics Research and Development Expense (Quarterly): 0.143M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Microbot Medical Inc | 2.06M |
| SELLAS Life Sciences Group Inc | 4.362M |
| Galectin Therapeutics Inc | 7.595M |
| Oragenics Inc | 0.879M |
| Anavex Life Sciences Corp | 11.56M |